Clinical Trial Update: A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD [Phase 3]

View source ↗

Summary

A Phase 3 double-blind study evaluating the efficacy and safety of buntanetap versus placebo in early Parkinson's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Buntanetap

Snippet

Sponsor: Annovis Bio Inc. | Conditions: Parkinson's Disease, Idiopathic | Phase 3 | Status: COMPLETED | Results posted: 2025-03-03